APELOA, officially known as APELOA Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of high-quality generic drugs and active pharmaceutical ingredients (APIs). With a commitment to innovation, APELOA offers a diverse portfolio of products, including oncology medications and cardiovascular treatments, distinguished by their rigorous quality standards and competitive pricing. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. Recognised for its dedication to research and development, APELOA continues to contribute to global healthcare solutions, solidifying its reputation as a trusted name in the pharmaceutical sector.
How does APELOA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
APELOA's score of 19 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, APELOA, headquartered in China (CN), reported no specific carbon emissions data, indicating a lack of disclosed Scope 1, 2, or 3 emissions figures. The absence of emissions data suggests that the company may still be in the process of establishing comprehensive reporting practices or has not yet quantified its carbon footprint. Despite the lack of specific emissions data, APELOA is associated with Apeloa Pharmaceutical Co., Ltd, which may influence its climate commitments and reporting standards. However, there are currently no documented reduction targets or climate pledges from APELOA, indicating a potential area for future development in their sustainability strategy. As the company continues to evolve, it may benefit from adopting industry-standard climate initiatives and setting measurable targets to enhance its environmental performance and transparency.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
APELOA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.